INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $551 | +8.7% | 41,037 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $507 | -99.9% | 41,037 | -28.3% | 0.00% | 0.0% |
| Q3 2022 | $797,000 | +169.3% | 57,195 | +166.7% | 0.00% | – |
| Q2 2022 | $296,000 | -70.5% | 21,442 | -65.2% | 0.00% | -100.0% |
| Q1 2022 | $1,002,000 | +45.0% | 61,615 | +45.2% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | +265.6% | 42,421 | +454.3% | 0.00% | – |
| Q4 2020 | $189,000 | +626.9% | 7,653 | +1079.2% | 0.00% | – |
| Q3 2020 | $26,000 | -92.0% | 649 | -90.4% | 0.00% | – |
| Q2 2020 | $325,000 | +282.4% | 6,795 | +401.1% | 0.00% | – |
| Q1 2020 | $85,000 | – | 1,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |